These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34638982)

  • 61. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
    Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
    Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer.
    Athyala PK; Kanwar JR; Alameen M; Kanwar RK; Krishnakumar S; Watson J; Vetrivel U; Narayanan J
    Biochem Biophys Res Commun; 2016 Jan; 469(2):257-62. PubMed ID: 26642954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular characterization of a fully human chimeric T-cell antigen receptor for tumor-associated antigen EpCAM.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    J Biomed Biotechnol; 2012; 2012():853879. PubMed ID: 22547929
    [TBL] [Abstract][Full Text] [Related]  

  • 64. v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.
    Ju X; Jiao X; Ertel A; Casimiro MC; Di Sante G; Deng S; Li Z; Di Rocco A; Zhan T; Hawkins A; Stoyanova T; Andò S; Fatatis A; Lisanti MP; Gomella LG; Languino LR; Pestell RG
    Cancer Res; 2016 Nov; 76(22):6723-6734. PubMed ID: 27634768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.
    Žagar T; Pavšič M; Gaber A
    PeerJ; 2021; 9():e11484. PubMed ID: 34055495
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance.
    Tavsan Z; Ayar Kayalı H
    Cell Adh Migr; 2020 Dec; 14(1):57-68. PubMed ID: 32091301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17.
    Wanger TM; Dewitt S; Collins A; Maitland NJ; Poghosyan Z; Knäuper V
    Cell Signal; 2015 Jul; 27(7):1325-35. PubMed ID: 25817572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of Anti-Trop2 Extracellular Domain Antibodies Generated Against Peptide and Protein Immunogens for Targeting Trop2-Positive Tumour Cells.
    Kamble PR; Kulkarni B; Malaviya A; Bajaj M; Breed AA; Jagtap D; Mahale S; Pathak BR
    Appl Biochem Biotechnol; 2024 Jun; 196(6):3402-3419. PubMed ID: 37656352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EpCAM (CD326) finding its role in cancer.
    Baeuerle PA; Gires O
    Br J Cancer; 2007 Feb; 96(3):417-23. PubMed ID: 17211480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors.
    Menz A; Lony N; Lennartz M; Dwertmann Rico S; Schlichter R; Kind S; Reiswich V; Viehweger F; Dum D; Luebke AM; Kluth M; Gorbokon N; Hube-Magg C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Jacobsen F; Marx AH; Steurer S; Minner S; Burandt E; Krech T; Lebok P; Weidemann S
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786342
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
    Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D
    J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epithelial cell adhesion molecule fragments and signaling in primary human liver cells.
    Gerlach JC; Foka HG; Thompson RL; Gridelli B; Schmelzer E
    J Cell Physiol; 2018 Jun; 233(6):4841-4851. PubMed ID: 29150960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells.
    Ng VY; Ang SN; Chan JX; Choo AB
    Stem Cells; 2010 Jan; 28(1):29-35. PubMed ID: 19785009
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
    Schmetzer O; Moldenhauer G; Nicolaou A; Schlag P; Riesenberg R; Pezzutto A
    Immunol Lett; 2012 Apr; 143(2):184-92. PubMed ID: 22387297
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.
    Trzpis M; McLaughlin PM; de Leij LM; Harmsen MC
    Am J Pathol; 2007 Aug; 171(2):386-95. PubMed ID: 17600130
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver.
    Okabe M; Tsukahara Y; Tanaka M; Suzuki K; Saito S; Kamiya Y; Tsujimura T; Nakamura K; Miyajima A
    Development; 2009 Jun; 136(11):1951-60. PubMed ID: 19429791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ginsenoside Rb3 Alleviates CSE-induced TROP2 Upregulation through p38 MAPK and NF-κB Pathways in Basal Cells.
    Li H; Cui L; Liu Q; Dou S; Wang W; Xie M; Xu X; Zheng C; Li T; Huang S; Cui X; Xiao W
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):747-759. PubMed ID: 33705682
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.